Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs

  • Anne Cammas
  • , Frédéric Pileur
  • , Sophie Bonnal
  • , Stephen M. Lewis
  • , Nicolas Lévêque
  • , Martin Holcik
  • , Stéphan Vagner

Research output: Contribution to journalArticlepeer-review

Abstract

Heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is a nucleocytoplasmic shuttling protein that regulates gene expression through its action on mRNA metabolism and translation. The cytoplasmic redistribution of hnRNP A1 is a regulated process during viral infection and cellular stress. Here, we show that hnRNP A1 is an internal ribosome entry site (IRES) trans-acting factor that binds specifically to the 5′ untranslated region of both the human rhinovirus-2 and the human apoptotic peptidase activating factor 1 (apaf-1) mRNAs, thereby regulating their translation. Furthermore, the cytoplasmic redistribution of hnRNP A1 after rhinovirus infection leads to enhanced rhinovirus IRES-mediated translation, whereas the cytoplasmic relocalization of hnRNP A1 after UVC irradiation limits the UVC-triggered translational activation of the apaf-1 IRES. Therefore, this study provides a direct demonstration that IRESs behave as translational enhancer elements regulated by specific traws-acting mRNA binding proteins in given physiological conditions. Our data highlight a new way to regulate protein synthesis in eukaryotes through the subcellular relocalization of a nuclear mRNA-binding protein.

Original languageEnglish
Pages (from-to)5048-5059
Number of pages12
JournalMolecular Biology of the Cell
Volume18
Issue number12
DOIs
Publication statusPublished - 1 Jan 2007
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs'. Together they form a unique fingerprint.

Cite this